Department of Health Economics, Center for Public Health, Medical University of Vienna, Kinderspitalgasse 15, 1090, Vienna, Austria.
Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Pharmacoeconomics. 2022 Dec;40(12):1221-1234. doi: 10.1007/s40273-022-01194-y. Epub 2022 Oct 6.
Preference differences between countries and populations justify the use of country-specific value sets for the EQ-5D instruments. There are no clear criteria based on which the selection of value sets for countries without a national value set should be made. As part of the European PECUNIA project, this study aimed to identify factors contributing to differences in preference-based valuations and develop supra-national value sets for homogenous country clusters in Europe.
A literature review was conducted to identify factors relevant to variations in the EQ-5D-3L/5L health state valuations across countries. Factors fulfilling the pre-specified criteria of validity, reliability, international feasibility and comparability were used to group 27 European Union member states, the European Free Trade Association countries and the UK. Clusters of countries were developed based on the frequency of their appearance in the same grouping. The supra-national value sets were estimated for these clusters from the coefficients of existing published valuation studies using the ordinary least-squares model.
Ten factors were identified from 69 studies. From these, five grouping variables: (1) culture and religion; (2) linguistics; (3) healthcare system typology; (4) healthcare system financing; and (5) sociodemographic aspects were derived to define the groups of homogenous countries. Frequency-based grouping revealed five cohesive clusters: English-speaking, Nordic, Central-Western, Southern and Eastern European.
European countries were clustered considering variables that may relate to differences in health state valuations. Supra-national value sets provide optimised proxy value set selection in the lack of a national value set and/or for regional decision making.
国家和人群之间的偏好差异证明了使用特定于国家的 EQ-5D 工具价值集是合理的。对于没有国家价值集的国家,选择价值集没有明确的标准。作为欧洲 PECUNIA 项目的一部分,本研究旨在确定导致偏好评估差异的因素,并为欧洲同质国家集群开发跨国界价值集。
进行了文献回顾,以确定与各国 EQ-5D-3L/5L 健康状况估值差异相关的因素。满足有效性、可靠性、国际可行性和可比性预先规定标准的因素用于对 27 个欧盟成员国、欧洲自由贸易联盟国家和英国进行分组。根据它们在同一分组中出现的频率来开发国家集群。使用普通最小二乘法模型,从现有已发表的估值研究的系数中为这些集群估算跨国界价值集。
从 69 项研究中确定了 10 个因素。从中得出了五个分组变量:(1)文化和宗教;(2)语言;(3)医疗保健系统类型学;(4)医疗保健系统融资;和(5)社会人口学方面,以定义同质国家群体。基于频率的分组揭示了五个紧密的集群:英语国家、北欧国家、中西欧国家、南欧国家和东欧国家。
考虑了可能与健康状况估值差异相关的变量,对欧洲国家进行了聚类。在缺乏国家价值集的情况下或用于区域决策,跨国界价值集提供了优化的代理价值集选择。